AMD3100 (plerixafor)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AMD3100 (plerixafor), covering 2012-07-11 to 2014-02-11. Get the full timeline:
Most recent: Clinical Trial Update: AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS [Phase 1, Phase 2]